Citadel Advisors - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 63 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$639,047
-32.7%
371,539
-23.7%
0.00%
Q2 2023$949,354
-53.3%
486,848
-33.4%
0.00%
Q1 2023$2,032,916
+16.6%
731,265
+44.7%
0.00%
Q4 2022$1,742,992
+22.7%
505,215
-8.7%
0.00%
Q3 2022$1,421,000
-11.1%
553,110
-16.2%
0.00%
Q2 2022$1,598,000
-54.2%
660,287
-22.0%
0.00%
-100.0%
Q1 2022$3,489,000
-60.5%
846,796
+23.2%
0.00%
-50.0%
Q4 2021$8,838,000
+74.4%
687,281
+46.4%
0.00%
Q3 2021$5,068,000
+474.0%
469,320
+385.3%
0.00%
Q2 2021$883,000
-81.3%
96,701
-80.7%
0.00%
-100.0%
Q1 2021$4,714,000
+811.8%
499,896
+543.0%
0.00%
Q2 2020$517,000
-11.9%
77,750
-22.9%
0.00%
Q1 2020$587,000
-31.2%
100,820
+6.0%
0.00%
Q4 2019$853,000
+9.4%
95,101
+5.2%
0.00%
Q3 2019$780,000
-52.4%
90,376
-38.6%
0.00%
-100.0%
Q2 2019$1,640,000
+69.2%
147,216
+102.2%
0.00%
Q1 2019$969,000
+407.3%
72,821
+488.6%
0.00%
Q4 2018$191,000
-79.1%
12,371
-80.8%
0.00%
Q3 2018$916,00064,3060.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders